|
JSM Activity #505This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions. To View the Program: You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time. |
|
|
Legend: = Applied Session,
= Theme Session,
= Presenter |
505 | Thu, 8/11/05, 10:30 AM - 12:20 PM | MCC-200 DE |
Nonrandomized Pharmaceutical Studies - Invited - Papers | ||
Section on Health Policy Statistics, Section on Physical and Engineering Sciences, Business and Economics Statistics Section, Biometrics Section, WNAR, Section on Quality and Productivity, Biopharmaceutical Section | ||
Organizer(s): W. Scott Clark, Eli Lilly and Company | ||
Chair(s): Shiva Sajjan, Merck & Co., Inc. | ||
10:35 AM | Lilly Experience with Nonstandard Clinical Studies — Pandurang M. Kulkarni, Eli Lilly and Company; W. Scott Clark, Eli Lilly and Company | |
11:00 AM | Do You Believe in RCTs or Observational Studies? — Suna Barlas, Merck & Co., Inc. | |
11:25 AM | Deriving Useful Information from Nonrandomized Studies: The Canadian Experience — Muhammad Mamdani, University of Toronto | |
11:50 AM | Disc: Robert L. Obenchain, U.S. Medical Outcomes Research, Eli Lilly | |
12:10 PM | Floor Discussion | |
JSM 2005
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |